| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c63cd52dd9511a65ad4925da0df385d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-287
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22 |
| filingDate |
2012-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_014a388aa637d88bbdf07c849518ed04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e6b633e9c6fe7532c07259f39fb114f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e127d1efba4252eea8d64558014af2ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc297ad97bbfb35cb9b1b6a52b2c7e60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b76f0968a337b297dfa6d24c3c066051 |
| publicationDate |
2012-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101207781-B1 |
| titleOfInvention |
A composition for the prevention and treatment of neurostable and cerebral nervous system-related anxiety, which contains a compound isolated from the extracts of Gaengkuk as an active ingredient |
| abstract |
The present invention relates to a composition containing a compound isolated from the extract of gakguk as an active ingredient, specifically, acecetin-7- O -glucuronide or luteolin-7- O -glucuro which is a compound of the present invention. As a result of testing for depression through experiments with elevated cruciforms, it was found that increasing the time and number of stays in the open space in the raised crucifers resulted in anti-anxiety effect, thereby preventing the composition from preventing depression. And as a therapeutic pharmaceutical composition or dietary supplement. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102055499-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20130136412-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170022431-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200124892-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190119824-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101702164-B1 |
| priorityDate |
2012-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |